Abstract Myxoinflammatory fibroblastic sarcoma (MIFS) is a rare low-grade sarcoma of the distal extremities characterized by a myxohyaline stroma, a dense inflammatory infiltrate and virocyte-and lipoblast-like giant cells. Up to now, only two cases have been investigated cytogenetically, showing complex and heterogeneous karyotypes, in part with supernumerary ring chromosomes. We characterized two further cases of MIFS immunohistochemically and performed comparative genomic hybridization as well as DNA image cytometry analyses. Both tumors showed the characteristic histomorphological pattern of MIFS and were positive for Vimentin and CD68. Moreover, both cases presented aberrant karyotypes including distinct DNA copy number changes involving chromosome 7 and disclosed DNA aneuploidy.
Introduction
In 1998, Montgomery et al. [14] first described inflammatory myxohyaline tumors of the distal extremities with virocyte or Reed-Sternberg-like cells as a distinct tumor entity with unique histologic features. In the same year, Meis-Kindblom et al. coined the shorter term acral myxoinflammatory fibroblastic sarcoma (MIFS) for the same lesion, usually presenting as poorly circumscribed multinodular mass of the distal extremities ranging from less than 1 to 8 cm in size [2, 12] . Patients typically report a history of slowly growing and painless tumors that only occasionally are associated with pain or decreased mobility [2] . Histologically, MIFS exhibit a dense inflammatory infiltrate, predominantly consisting of lymphocytes and plasma cells, embedded in an alternating myxoid and hyaline stroma. Three main types of neoplastic cells can be distinguished, namely spindle-shaped cells, bizarre virocyte, or ganglion-like cells with enlarged nuclei and often huge, inclusion-like nucleoli and multinucleated lipoblast-like cells of variable size. Tumor cells are dispersed through the myxohyaline stroma as single cells or form coherent nodules [2, 9, 12-14, 17, 18] . The rates of local recurrences range between 22 and 67%, probably depending on differences in surgical treatment, whereas distant metastases are exceedingly rare (<2% of all reported cases) [2, 12, 14, 17] .
Cytogenetic data on chromosomal aberrations of MIFS are scarce, and up to now, only two cases have been investigated so far. One of them revealed a complex karyotype with a reciprocal translocation t(1;10)(p22;q24) in addition to the loss of chromosome 3 and 13, while the other exhibited supernumerary ring chromosomes and a derivate chromosome 13 with additional material on the short arm [9, 11] . In this paper, we report two further cases of MIFS investigated by immunohistochemistry, comparative genomic hybridization (CGH), and DNA image cytometry.
Materials and methods

Immunohistochemistry
The biopsy specimens were formalin-fixed, routinely processed, paraffin-embedded, and stained with hematoxylin and eosin. The panel of applied primary antibodies, dilutions, and different methods of tissue preparation and pretreatment, respectively, are listed in Table 1 . All primary antibodies were diluted in a 1% solution of bovine serum albumin in phosphate-buffered saline (pH 7.4) and incubated for 30 min at room temperature. After incubation with the biotinylated secondary antibody, the avidinbiotin-peroxidase complex was applied for 30 min, and color development was performed using diamino-benzidine (DAB). The slides were counterstained with hemalaun, dehydrated, and mounted.
Comparative genomic hybridization
For CGH, tumor DNA was isolated from formalin-fixed and deparaffinized tumor tissue by proteinase K digestion (2 mg/ml final concentration; Roche, Mannheim, Germany) followed by spin column purification (Qiagen, Hilden, Germany). Labeling of tumor DNA with biotin-16-dUTP (Roche, Mannheim, Germany) and normal reference DNA with digoxigenin-11-dUTP (Roche) was performed by standard nick translation. The denatured DNA probe containing 2 μg of tumor DNA, 1.5 μg of reference DNA, and 80 μg of COT-1 DNA was hybridized for 3 days to normal metaphase spreads on glass slides (15×15 mm cover glass area). The slides were then washed, blocked with bovine serum albumin solution, and incubated with fluorescein-conjugated avidin (Vector Laboratories, Burlingame, CA) and rhodamine-conjugated antidigoxigenin (Roche). Finally, the slides were washed and mounted in antifade solution (Vector Laboratories) containing 2.5 μg/ml of 4,6-diamino-2-phenylindole (DAPI) counterstain. Image acquisition was performed on a Zeiss Axioskop fluorescence microscope (Zeiss, Göttingen, Germany) equipped with three separate bandpass filters (DAPI bandpass, Green single bandpass, Red single bandpass) and a high sensitive monochrome charge coupled device camera (Photometrics, Tuscon, AZ). For each analysis, the averaged chromosome-specific green to red fluorescence ratios and their 95% confidence intervals (CI) from at least ten well-selected metaphases were plotted using the Quips CGH software (distributed through Applied Imaging, Newcastle, UK). Relative copy number changes were interpreted as gains when the average greento-red ratio exceeded 1.2 or 2 (high-level amplification), and as losses when the corresponding ratio was less than 0.8. Exceptionally, in cases with only trends not reaching the aforementioned thresholds, deviations from normal were classified as gains or losses when the 95% CI varied beyond the ratio of 1.0. An event was defined as a gain or a loss of (part of) a chromosomal arm. Chromosomal regions 1p32-pter, 13p, 14p, 15p, 19, 21p, 22p, telomeres and constitutive heterochromatic regions at 1q, 9q, 16q, and Yq reported to produce false results by CGH were excluded from all analyses [7] .
DNA image cytometry
The specimens were evaluated with the semiautomatic AUTOCYTETM cell analytical system (Carl Zeiss AG, CH 8706 Feldmeilen) using a Zeiss AxioplanTM microscope. On average, 135 (104-153) of the most abnormally looking tumor cells were selected as test cells, whereas 50 nuclei of lymphocytes were measured as internal standard. The histograms were analyzed following the recommendations of the European Society for Analytical and Cellular Pathology (ESACP) [3, 4] . Both stemlines and single events were considered. The key data of DNA cytometry, i.e., integrated optical density and nuclear area, were transferred to the server EUROQUANTTM (http://euroquant.med. tu-dresden.de) at the Institute of Pathology, Technical University/Dresden, which is available free of charge to any user for quality assurance [5] . There, the data were standardized and evaluated on the basis of statistic models, by which, the number of stemlines, their position on the ploidy axis, and their coefficient of variation are determined. EUROQUANT delivers the modal DNA values of peaks and the coefficient of variation (CV) value of stemlines and calculates several quality parameters defined by the ESACP (e.g., parameters for a control of measured glare factors and of the homogeneity of measurement) and compares them to established limit values. Single events were directly analyzed on the basis of the AUTOCYTE data. Ploidy classes were defined as follows: euploid/ diploid: 1.8-2.2 c; tetraploid/polyploid: 3.6-4.4 c; octaploid: 7.2-8.8 c; aneuploid: stemline outside of a euploid region (2 c, 4 c, 8 c, etc.), single events >8.8 c.
Results
Clinical findings
Clinical features of the two cases are summarized in Table 2 . One patient noticed a slowly growing painless mass in the right index finger and was treated surgically by local excision (case 1). The other patient suffered from pain in the right popliteal fossa and observed a slowly growing tumor that turned out to be located inside the tibial nerve (case 2). After histologic diagnosis, treatment consisted in isolated limb perfusion with tumor necrosis factor alpha (TNF-α) and Melphalan followed by neoadjuvant percutaneous radiotherapy and local excision without destruction of major fascicles. On histologic examination, no viable tumor was detectable anymore, and the patient did not sustain sensory or motor deficits (Fig. 1) . At initial surgery, both tumors showed a myxoid aspect with no signs of necrosis or hemorrhage on cut section. Patient 1 developed local recurrence 5 months after initial resection and underwent re-excision followed by another recurrence 16 months later. The second patient is still free of disease (follow-up 14 months).
Microscopical and immunohistochemical findings
Light microscopy showed cell-rich tumors containing myxoid and hyaline areas and zones of fibrosis (Fig. 2) . Tumor cells revealed pronounced nuclear polymorphism, including differences in nuclear size and form. Some cells were rather small and spindle-shaped, while others revealed big vesicular nuclei and prominent nucleoli, focally resembling ganglion cells or virocytes (Fig. 2f) . Additionally, multinucleated cells and lipoblast-like cells with multiple intracytoplasmatic mucin-containing vacuoles were present in all cases (Fig. 2a-c) . The inflammatory infiltrates were dense and particularly prominent in the fibrotic and myxoid areas of the tumors. Immunohistochemically all tumors were strongly positive for vimentin and focally positive for CD68 (not shown). Expression of CK22, CD15, CD30, epithelial membrane antigen (EMA), S100 protein, or desmin could not be detected in any of the two cases. Comparative genomic hybridization DNA copy number changes were identified in both cases (Table 3 , Fig. 3 ). The number of changes ranged from two (case 1) to three (case 2). There were no specific common gains or losses, but both investigated cases showed gains at chromosome 7.
DNA image cytometry (Fig. 2) . Immunohistochemically, the tumor cells stained positive for Vimentin and CD68. Cytogenetic data on chromosomal aberrations on MIFS are limited. To our knowledge, only two cases have been investigated by conventional cytogenetic and fluorescence in situ hybridization analyses so far. One case showed a derivate chromosome 13 with additional material on the short arm and supernumerary ring chromosomes, while the other exhibited a complex karyotype with a reciprocal translocation t(1;10) (p22;q24) and losses of chromosomes 3 and 13 [9, 11] . The two cases of the present study also revealed aberrant karyotypes involving gains at several different chromosomal regions. Although no specific common aberration was observed, both cases shared gains at chromosome 7. Losses of chromosomal regions were not detected. Furthermore, no chromosomal alterations were shared with the previously investigated two MIFS [9, 11] . DNA image cytometry revealed both tumors of our series to be DNA aneuploid, which has never been investigated so far.
In conclusion, the two MIFS of the present study show considerable genetic diversity, which is in keeping with the two previously investigated cases. However, no single marker or profile of DNA copy number changes characterizing all tumors could be detected. Further, cytogenetic or CGH analyses have to be awaited to define specific cytogenetic profiles of MIFS and possible separate subtypes of MIFS, respectively.
